Balyasny Asset Management
ANAC

Balyasny Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Balyasny Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-157,843
Closed -$8.44M – 1673
2016
Q1 		$8.44M Buy
157,843
+155,693
+7,242% +$11.5M 0.05% 439
2015
Q4 		$243K Sell
2,150
-3,660
-63% -$403K ﹤0.01% 1038
2015
Q3 		$684K Buy
5,810
+530
+10% +$69.2K 0.01% 775
2015
Q2 		$409K Buy
+5,280
New +$346K ﹤0.01% 895

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Balyasny Asset Management's ANAC Position: Q2 2016 in Review

Balyasny Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 157,843 shares — an estimated $8.44M sold.

Balyasny Asset Management first reported a position in ANAC in Q2 2015 and held it in 4 quarters. The position peaked at $8.44M in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Balyasny Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Balyasny Asset Management sold 157,843 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $8.44M.
  • Balyasny Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 4 quarters.
  • Balyasny Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $8.44M in Q1 2016.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Balyasny Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.